Want to see VBIO full AI Analyst Report?

Valion Bio (VBIO) Ratios

172 Followers

Valion Bio Ratios

VBIO's free cash flow for Q2 2026 was $-0.99. For the 2026 fiscal year, VBIO's free cash flow was decreased by $ and operating cash flow was $-17.01. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 24	Dec 23
Liquidity Ratios
Current Ratio	―	20.13	9.70	20.13	3.32
Quick Ratio	―	20.13	8.53	20.13	2.78
Cash Ratio	―	19.57	7.36	19.57	2.42
Solvency Ratio	―	-0.60	-19.50	-0.60	-5.11
Operating Cash Flow Ratio	―	-10.83	-21.05	-10.83	-6.07
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00	0.00
Net Current Asset Value	$ ―	$ -1.80M	$ 2.37M	$ -1.80M	$ 3.08M
Leverage Ratios
Debt-to-Assets Ratio	―	0.20	0.00	0.20	0.07
Debt-to-Equity Ratio	―	0.38	0.00	0.38	0.10
Debt-to-Capital Ratio	―	0.28	0.00	0.28	0.09
Long-Term Debt-to-Capital Ratio	―	0.28	0.00	0.28	0.00
Financial Leverage Ratio	―	1.88	1.11	1.88	1.44
Debt Service Coverage Ratio	―	-53.71	0.00	-53.71	0.00
Interest Coverage Ratio	―	-54.10	0.00	-54.10	0.00
Debt to Market Cap	―	0.15	0.00	15.49	0.00
Interest Debt Per Share	―	5.71	0.00	22.97	7.91
Net Debt to EBITDA	―	0.79	0.38	0.79	0.38
Profitability Margins
Gross Profit Margin	―	0.00%	0.26%	8.38%	24.40%
EBIT Margin	―	0.00%	-725.77%	-2054.19%	-701.11%
EBITDA Margin	―	0.00%	-680.64%	-2052.88%	-685.54%
Operating Profit Margin	―	0.00%	-725.77%	-2067.54%	-701.11%
Pretax Profit Margin	―	0.00%	-725.00%	-2092.41%	-701.02%
Net Profit Margin	―	0.00%	-725.00%	-2324.08%	-701.02%
Continuous Operations Profit Margin	―	0.00%	-725.00%	-2092.41%	-701.02%
Net Income Per EBT	―	111.07%	100.00%	111.07%	100.00%
EBT Per EBIT	―	101.20%	99.89%	101.20%	99.99%
Return on Assets (ROA)	―	-28.09%	-201.46%	-28.09%	-159.86%
Return on Equity (ROE)	―	-52.85%	-223.08%	-52.85%	-230.28%
Return on Capital Employed (ROCE)	―	-25.51%	-223.31%	-25.51%	-219.52%
Return on Invested Capital (ROIC)	―	-25.51%	-223.31%	-25.51%	-208.79%
Return on Tangible Assets	―	-30.23%	-201.46%	-30.23%	-159.86%
Earnings Yield	―	-21.19%	-0.33%	-2130.62%	-577.52%
Efficiency Ratios
Receivables Turnover	―	0.00	11.30	382.00	6.76
Payables Turnover	―	0.00	6.22	1.33	1.25
Inventory Turnover	―	0.00	2.44	0.00	1.18
Fixed Asset Turnover	―	0.00	6.55	0.00	2.50
Asset Turnover	―	0.00	0.28	0.01	0.23
Working Capital Turnover Ratio	―	0.00	0.28	0.05	0.39
Cash Conversion Cycle	―	0.00	123.30	-274.36	71.66
Days of Sales Outstanding	―	0.00	32.29	0.96	54.01
Days of Inventory Outstanding	―	0.00	149.66	0.00	310.39
Days of Payables Outstanding	―	0.00	58.64	275.31	292.74
Operating Cycle	―	0.00	181.95	0.96	364.40
Cash Flow Ratios
Operating Cash Flow Per Share	―	-6.06	-0.02	-24.36	-182.44
Free Cash Flow Per Share	―	-6.09	-0.02	-26.38	-184.97
CapEx Per Share	―	0.03	0.00	2.02	2.53
Free Cash Flow to Operating Cash Flow	―	1.01	1.00	1.08	1.01
Dividend Paid and CapEx Coverage Ratio	―	-184.18	0.00	-12.05	-72.13
Capital Expenditure Coverage Ratio	―	-184.18	0.00	-12.05	-72.13
Operating Cash Flow Coverage Ratio	―	-1.08	0.00	-1.08	-23.07
Operating Cash Flow to Sales Ratio	―	0.00	-7.34	-18.32	-7.24
Free Cash Flow Yield	―	-16.80%	-0.34%	-1819.11%	-604.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-4.62	-299.31	-0.05	-0.17
Price-to-Sales (P/S) Ratio	―	0.00	2.17K	1.09	1.21
Price-to-Book (P/B) Ratio	―	2.49	667.70	0.02	0.40
Price-to-Free Cash Flow (P/FCF) Ratio	―	-5.95	-295.65	-0.05	-0.17
Price-to-Operating Cash Flow Ratio	―	-5.98	-295.65	-0.06	-0.17
Price-to-Earnings Growth (PEG) Ratio	―	0.08	3.37	<0.01	>-0.01
Price-to-Fair Value	―	2.49	667.70	0.02	0.40
Enterprise Value Multiple	―	-4.55	-318.44	0.74	0.20
Enterprise Value	―	35.70M	1.69B	-5.77M	-1.60M
EV to EBITDA	―	-4.55	-318.44	0.74	0.20
EV to Sales	―	0.00	2.17K	-15.12	-1.36
EV to Free Cash Flow	―	-5.07	-295.30	0.76	0.19
EV to Operating Cash Flow	―	-5.10	-295.30	0.83	0.19
Tangible Book Value Per Share	―	12.60	<0.01	50.65	76.74
Shareholders’ Equity Per Share	―	14.54	<0.01	58.45	76.74
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	0.00	0.00
Revenue Per Share	―	0.00	<0.01	1.33	25.21
Net Income Per Share	―	-7.68	-0.02	-30.89	-176.72
Tax Burden	―	1.11	1.00	1.11	1.00
Interest Burden	―	1.02	1.00	1.02	1.00
Research & Development to Revenue	―	0.00	1.68	8.20	1.41
SG&A to Revenue	―	0.00	5.58	12.48	4.04
Stock-Based Compensation to Revenue	―	0.00	0.29	1.48	0.23
Income Quality	―	0.88	1.01	-1.16	1.03

Currency in USD